Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|August 4, 2020
Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenitaMartin Kirschner, Margherita Vieri, Kim Kricheldorf, et al.
Cancers|February 10, 2024
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic MastocytosisNicole Naumann, Martina Rudelius, Johannes Lübke, et al.
Hematological Oncology|November 16, 2022
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemiaThomas Wilhelm, Marcelo A S Toledo, Ilka Simons, et al.
Infection|July 10, 2026
Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation studyOliver Kriege, Boris Böll, Nicole Brüder, et al.
Leukemia & Lymphoma|February 8, 2025
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemiaFabian Lang, Andreas Voss, Guido Kobbe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 11, 2025
Psychological burden, quality of life, problems, and parental concerns of single mothers with cancer: a cross-sectional comparisonSteffen Holsteg, Maike K Klett, Anna-Maria Kisić, et al.
Blood|December 19, 2024
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVHAustin Kulasekararaj, Morag Griffin, Caroline Piatek, et al.
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Oncotarget|February 25, 2016
DNA methylation in PRDM8 is indicative for dyskeratosis congenitaCarola I Weidner, Qiong Lin, Carina Birkhofer, et al.
Nature Communications|February 9, 2020
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricideSabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, et al.
Pageof 13